View Item 

Show simple item record

MOLECULAR MODELS FOR PHARMACOLOGICAL TOLERANCE AND ADDICTION *

dc.contributor.authorKrooth, Robert S.en_US
dc.date.accessioned2010-06-01T18:19:55Z
dc.date.available2010-06-01T18:19:55Z
dc.date.issued1971-07en_US
dc.identifier.citationKrooth, Robert S. (1971). "MOLECULAR MODELS FOR PHARMACOLOGICAL TOLERANCE AND ADDICTION * ." Annals of the New York Academy of Sciences 179(1 Drug Metabolism in Man ): 548-560. <http://hdl.handle.net/2027.42/71541>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71541
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5285391&dopt=citationen_US
dc.format.extent683404 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1971 The New York Academy of Sciencesen_US
dc.titleMOLECULAR MODELS FOR PHARMACOLOGICAL TOLERANCE AND ADDICTION *en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumLawrence C. Buhl Center for Human Genetics Department of Human Genetics University of Michigan Medical School Ann Arbor, Mich.en_US
dc.identifier.pmid5285391en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71541/1/j.1749-6632.1971.tb46932.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1971.tb46932.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceAppel, S. 1968. Purification and kinetic properties of brain orotidine-5′-monophosphate decarboxylase. J. Biol. Chem. 243: 3924 – 3929.en_US
dc.identifier.citedreferenceBeckwith, J. R., A. B. Pardee, R. Austrian & F. Jacob. 1962. Coordinate synthesis of the enzymes in the pyrimidine pathway of E. Coli. J. Molec. Biol. 5: 618 – 634.en_US
dc.identifier.citedreferenceBurns, J. J. 1964. Implications of enzyme induction for drug therapy. Amer. J. Med. 37: 327 – 331.en_US
dc.identifier.citedreferenceCihÀk, A. & F. Sorm. 1967. Metabolic transformation of 5-azaorotate: cause of marked inhibition of orotidine-5′-monophosphate decarboxylase. Biochim. Biophys. Acta 149: 314 – 316.en_US
dc.identifier.citedreferenceCihÀk, A., J. Vesely & F. Sorm. 1968. Inhibition of pyrimidine biosynthesis of 5-azaorotate in mouse liver. Collection Czechoslov. Chem. Commun. 33: 1178 – 1787.en_US
dc.identifier.citedreferenceDavis, R. 1967. Channeling in Neurospora metabolism. In Organizational Biosynthesis. H. J. Vogel, J. O. Lampen & V. Bryson, Eds.: 303 – 322. Academic Press, Inc. New York, NY.en_US
dc.identifier.citedreferenceFallon, H. J., L. H. Smith Jr., M. Lotz, J. B. Graham & C. H. Burnett. 1963. Hereditary orotic aciduria. Trans. Ass. Amer. Phys. 76: 76.en_US
dc.identifier.citedreferenceFox, R. M., W. J. O'Sullivan & B. G. Firkin. 1969. Orotic aciduria: differing enzyme patterns. Amer. J. Med. 47: 332 – 336.en_US
dc.identifier.citedreferenceFink, G. R. 1970. Gene clusters and the regulation of biosynthetic pathways in fungi. In Metabolic Pathways. Academic Press, Inc. New York, N. Y. In press.en_US
dc.identifier.citedreferenceGoldstein, D. B. & A. Goldstein. 1961. Possible role of enzyme inhibition and repression in drug tolerance. Biochem. Pharmacol. 8: 8.en_US
dc.identifier.citedreferenceGross, S. R. 1969. Genetic regulatory mechanisms in the fungi. Ann. Rev. Genetics 3: 395 – 424.en_US
dc.identifier.citedreferenceHall, T. C., D. Roberts & D. H. Kessel. 1966. Methotrexate and folic reductase in human cancer. Europ. J. Cancer 2: 135 – 142.en_US
dc.identifier.citedreferenceHowell, R. R., J. R. Klinenberg & R. S. Krooth. 1967. Enzyme studies on diploid cell strains developed from patients with hereditary orotic aciduria. Johns Hopkins Med. J. 120: 81 – 88.en_US
dc.identifier.citedreferenceKasbekar, P. K., A. Nagabhushanam & P. Greenberg. 1964. Purification and properties of orotic acid-decarboxylating enzymes from calf thymus. J. Biol. Chem. 239: 4245 – 4249.en_US
dc.identifier.citedreferenceKrooth, R. S. 1968. Gene action in diploid cell strains. Proceedings XII Internat. Congr. Genetics 2: 106 – 107.en_US
dc.identifier.citedreferenceKrooth, R. S. 1970. Studies bearing on the regulation of uridine-5′-monophosphate biosynthesis in human diploid cells. In Control Mechanisms in Expression of Cellular Phenotypes. H. Padykula, Ed. Academic Press, Inc. New York, NY. In press.en_US
dc.identifier.citedreferenceKrooth, R. S. 1969. Gene action in diploid cell strains. In Comparative Mammalian Cytogenetics. K. Benirschke, Ed.: 154 – 179. Springer-Verlag. New York, NY.en_US
dc.identifier.citedreferenceKrooth, R. S. 1964. Properties of diploid cell strains developed from patients with an inherited abnormality of uridine biosynthesis. Cold Spring Harbor Symp. Quant. Biol. 29: 189 – 212.en_US
dc.identifier.citedreferenceKrooth, R. S. 1964b. Somatic Cell Genetics: 288. University of Michigan Press. Ann Arbor, Mich.en_US
dc.identifier.citedreferenceLacroute, F. 1968. Regulation of pyrimidine biosynthesis in Saccharomyces cerevisiae. J. Bact. 95: 824 – 832.en_US
dc.identifier.citedreferenceLevintow, L. & H. Eagle. 1961. Biochemistry of cultured mammalian cells. Ann. Rev. of Biochem. 30: 605 – 640.en_US
dc.identifier.citedreferenceMa, R. & R. S. Krooth. 1970. Unpublished observations.en_US
dc.identifier.citedreferencePinsky, L. & R. S. Krooth. 1967a. Studies on the genetic control of pyrimidine biosynthesis in human diploid cell strains. I. Effect of 6-azauridine on cellular phenotype. Proc. Nat. Acad. Sci. U.S.A. 57: 925 – 932.en_US
dc.identifier.citedreferencePinsky, L. & R. S. Krooth. 1967b. Studies on the control of pyrimidine biosynthesis in human diploid cell strains. II. Effects of 5-azaorotic acid, barbituric acid and pyrimidine precursors on cellular phenotype. Proc. Nat. Acad. Sci. U.S.A. 57: 1267 – 1274.en_US
dc.identifier.citedreferenceSmith, L. H., C. M. Huguley & J. A. Bain. 1966. Hereditary orotic aciduria. In The Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden & D. S. Frederickson, Eds. 2nd ed.: Chap. 33, 739 – 758. McGraw-Hill Book Co., Inc. New York, NY.en_US
dc.identifier.citedreferenceSmith, L. H., M. Sullivan & C. M. Huguley, Jr. 1961. Pyrimidine metabolism in man. IV. Enzymatic defect of orotic aciduria. J. Clin. Invest. 40: 656 – 664.en_US
dc.identifier.citedreferenceSmith, L. H. & F. A. Baker. 1959. Pyrimidine metabolism in man. I. The biosynthesis of orotic acid. J. Clin. Invest. 38: 798 – 809.en_US
dc.identifier.citedreferenceWuu, K. D. & R. S. Krooth. 1968. Dihydroorotic acid dehydrogenase activity of human diploid cell strains. Science. 160: 539 – 541.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1749-6632.1971.tb46932.x.pdf
Size:
667.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.